Potent Maturation of Monocyte-Derived Dendritic Cells After CD40L Lentiviral Gene Delivery
Authors:
- Nori KasaharaNKNori Kasahara
- Patricia M. B. FavaroPFPatricia M. B. Favaro
- Roy LauRLRoy Lau
- Huy Q. TaHTHuy Q. Ta
- Jeffrey S. WeberJWJeffrey S. Weber
- Renata StripeckeRSRenata Stripecke
- 1 September 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Immunotherapy
- Vol. 26 (5) , 451-460
Abstract
Dendritic cells (DCs) are being evaluated in immunization protocols to enhance immunity against infectious diseases and cancer. Interaction of T-helper cells expressing CD40 ligand (CD40L) with its cognate CD40 receptor on DCs leads to a mature DC phenotype, characterized by increased capacity of antigen presentation to cytotoxic T cells. The authors examined the ability of third-generation self-inactivating lentiviral vectors expressing CD40L to induce autonomous maturation of ex vivo expanded human monocyte-derived dendritic cells. Transduction with lentiviral vectors achieved a highly efficient gene transfer of CD40L to DCs, which correlated with phenotypic maturation as shown by the expression of immunologic relevant markers (CD83, CD80, MHCI) and secretion of IL-12, whereas DC phenotype was not affected by a control vector expressing only the green fluorescent protein marker. Addition of recombinant IFN-γ to DCs at the time of CD40L transduction further enhanced IL-12 production, and when co-cultured with allogeneic and autologous CD8+ and CD4+ T cells, a potent activation was observed. Autologous responses against an HLA-A2-restricted influenza peptide (Flu-M1) and a tumor-associated antigenic peptide (gp100 210M) were significantly enhanced when CD40L transduced DCs were used as antigen-presenting cells for in vitro stimulation of CD8+ cytotoxic T lymphocytes. These results demonstrate that endogenous expression of CD40L by lentivirally transduced DCs induced their autonomous maturation to a phenotype comparable to that induced by optimal concentrations of soluble CD40L, providing a novel tool for genetic manipulation of DCs.Keywords
This publication has 33 references indexed in Scilit:
- Effect of Adenovirus Gene Transfer Vectors on the Immunologic Functions of Mouse Dendritic CellsMolecular Therapy, 2002
- Cross-Strain Protection against Clinical and Laboratory Strains of Pseudomonas aeruginosa Mediated by Dendritic Cells Genetically Modified to Express CD40 Ligand and Pulsed with Specific Strains of Pseudomonas aeruginosaHuman Gene Therapy, 2001
- Dendritic cells rapidly undergo apoptosis in vitro following culture with activated CD4+ Vα24 natural killer T cells expressing CD40LImmunology, 2001
- Review: Gene-Modified Dendritic Cells for Use in Tumor VaccinesHuman Gene Therapy, 2000
- Transduction of Human PBMC-Derived Dendritic Cells and Macrophages by an HIV-1-Based Lentiviral Vector SystemMolecular Therapy, 2000
- Dendritic Cell Secretion of IL-15 Is Induced by Recombinant huCD40LT and Augments the Stimulation of Antigen-Specific Cytolytic T CellsCellular Immunology, 1999
- CD40 ligand inhibits Fas/CD95‐mediated apoptosis of human blood‐derived dendritic cellsEuropean Journal of Immunology, 1997
- Proliferating dendritic cell progenitors in human blood.Journal of Experimental Medicine, 1994
- Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.Journal of Experimental Medicine, 1994
- The CD40 Antigen and its LigandAnnual Review of Immunology, 1994